Sarepta Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2013
Total Assets: $291.6M
Liabilities Breakdown FY2013
Total Liabilities: $44.4M
Asset Breakdown
Total Assets: $291.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $257.0M | 88.1% |
| Accounts Receivable | $3.5M | 1.2% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $15.0M | 5.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $5.0M | 1.7% |
| Other Assets | $11.0M | 3.8% |
Liabilities Breakdown
Total Liabilities: $44.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $8.1M | 18.2% |
| Long-Term Debt | $1.6M | 3.6% |
| Other Liabilities | $34.7M | 78.2% |